Observational studyBritish journal of cancer2021

Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases.

Emad A Rakha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.